FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
2010 · Annals of Oncology · 181 citations
https://doi.org/10.1093/annonc/mdq585
S
Sadako Akashi‐Tanaka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
2.8K
Citations
27
h-index
77
i10-index
Sadako Akashi‐Tanaka is an academic researcher from Tokyo Women's Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & HER2/EGFR in Cancer Research. The author has an h-index of 27, co-authored 147 publications.
ORCID: 0000-0002-2065-7742Papers by this author
worksIpsilateral breast tumor recurrence (IBTR) after breast‐conserving treatment for early breast cancer
2005 · Cancer · 180 citations
https://doi.org/10.1002/cncr.21551
c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues
2000 · Journal of Surgical Oncology · 97 citations
https://doi.org/10.1002/(sici)1096-9098(200001)73:1<17::aid-jso5>3.0.co;2-2
Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
2020 · npj Breast Cancer · 40 citations
https://doi.org/10.1038/s41523-020-0163-1
Association between frequent CpG island methylation and HER2 amplification in human breast cancers
2009 · Carcinogenesis · 30 citations
https://doi.org/10.1093/carcin/bgp021
Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation
2005 · Journal of Clinical Pathology · 27 citations
https://doi.org/10.1136/jcp.2005.026096
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat